Jan eleven (Reuters) – Walgreens Boots Alliance Inc (WBA.O) has started a strategic evaluation of its U.K. based Boots company, Chief Executive Officer Rosalind Brewer stated on Tuesday, as the next largest U.S. pharmacy chain tries to restore the focus of its on U.S. healthcare.
The Boots industry has more than 2,200 retailers throughout the U.K., including pharmacies, beauty and health stores, among others, based on the chain’s site.
“This evaluation is a lot in line with the renewed priorities of ours and strategic direction. Particularly, our increased focus on U.S. healthcare. Even though the procedure is at an exploratory stage, we do look to shift quickly,” Brewer stated at the J.P Morgan Healthcare Conference.
The evaluation comes at a moment whenever the business, which had been created in 2014 following the acquisition of a stake in Alliance Boots by Walgreens, techniques beyond its drugstores with the investments of its in 2 smaller medical providers, VillageMD as well as CareCentrix.
Late last year, Walgreens similarly introduced its Walgreens Health device to give primary care products and pharmacies in stores, at home, or perhaps at a doctor’s office and through mobile app. read more.
Shoes U.K. similar pharmacy sales improved 8.8 % in the quarter ended November because of increased footfalls.